Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J F Robertson

Showing results (71-80 of 200) with videos related to

Pageof 20
Sort By:
Breast Cancer Research and Treatment|March 23, 2001
Selection of primary breast cancer patients for adjuvant endocrine therapy--is oestrogen receptor alone adequate?K L Cheung, R I Nicholson, R W Blamey, et al.
The British Journal of Surgery|December 1, 1989
Combined endocrine effects of LHRH agonist (Zoladex) and tamoxifen (Nolvadex) therapy in premenopausal women with breast cancerJ F Robertson, K J Walker, R I Nicholson, et al.
Breast Cancer Research and Treatment|February 16, 2000
Static disease on anastrozole provides similar benefit as objective response in patients with advanced breast cancerJ F Robertson, A Howell, A Buzdar, et al.
British Journal of Cancer|June 1, 1991
Failure of CA19-9 to detect asymptomatic colorectal carcinomaW M Thomas, J F Robertson, M R Price, et al.
American Journal of Clinical Oncology|October 1, 1989
Mitoxantrone--a useful palliative therapy in advanced breast cancerJ F Robertson, M R Williams, J H Todd, et al.
Journal of Pediatric Orthopedics|September 27, 2016
Prognostication in Developmental Dysplasia of the Hip Using the Ossific Nucleus Center Edge AngleGregory B Firth, Anthony J F Robertson, Yammesh Ramguthy, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1990
Weekly low dosage epirubicin in advanced breast cancerA R Dixon, J F Robertson, E Athanassiou, et al.
The Journal of Bone and Joint Surgery. British Volume|January 1, 1993
Timing of antibiotic administration in knee replacement under tourniquetJ B Richardson, A Roberts, J F Robertson, et al.
British Journal of Cancer|July 17, 1999
Anti-gonadotrophin releasing hormone antibodies inhibit the growth of MCF7 human breast cancer xenograftsE Jacobs, S A Watson, D Michaeli, et al.
European Journal of Cancer (Oxford, England : 1990)|August 17, 1999
Onapristone, a progesterone receptor antagonist, as first-line therapy in primary breast cancerJ F Robertson, P C Willsher, L Winterbottom, et al.
Pageof 20

Showing results (71-80 of 200) with videos related to

Sort By:
Pageof 20
Breast Cancer Research and Treatment|March 23, 2001
Selection of primary breast cancer patients for adjuvant endocrine therapy--is oestrogen receptor alone adequate?K L Cheung, R I Nicholson, R W Blamey, et al.
The British Journal of Surgery|December 1, 1989
Combined endocrine effects of LHRH agonist (Zoladex) and tamoxifen (Nolvadex) therapy in premenopausal women with breast cancerJ F Robertson, K J Walker, R I Nicholson, et al.
Breast Cancer Research and Treatment|February 16, 2000
Static disease on anastrozole provides similar benefit as objective response in patients with advanced breast cancerJ F Robertson, A Howell, A Buzdar, et al.
British Journal of Cancer|June 1, 1991
Failure of CA19-9 to detect asymptomatic colorectal carcinomaW M Thomas, J F Robertson, M R Price, et al.
American Journal of Clinical Oncology|October 1, 1989
Mitoxantrone--a useful palliative therapy in advanced breast cancerJ F Robertson, M R Williams, J H Todd, et al.
Journal of Pediatric Orthopedics|September 27, 2016
Prognostication in Developmental Dysplasia of the Hip Using the Ossific Nucleus Center Edge AngleGregory B Firth, Anthony J F Robertson, Yammesh Ramguthy, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1990
Weekly low dosage epirubicin in advanced breast cancerA R Dixon, J F Robertson, E Athanassiou, et al.
The Journal of Bone and Joint Surgery. British Volume|January 1, 1993
Timing of antibiotic administration in knee replacement under tourniquetJ B Richardson, A Roberts, J F Robertson, et al.
British Journal of Cancer|July 17, 1999
Anti-gonadotrophin releasing hormone antibodies inhibit the growth of MCF7 human breast cancer xenograftsE Jacobs, S A Watson, D Michaeli, et al.
European Journal of Cancer (Oxford, England : 1990)|August 17, 1999
Onapristone, a progesterone receptor antagonist, as first-line therapy in primary breast cancerJ F Robertson, P C Willsher, L Winterbottom, et al.
Pageof 20